Takeshi Ogo   Hiroto Shimokawahara   Hideyuki Kinoshita   Seiichiro Sakao   Kohtaro Abe   Satoaki Matoba   Hirohiko Motoki   Noriaki Takama   Junya Ako   Yasuhiro Ikeda   Shuji Joho   Hisataka Maki   Takahiro Saeki   Teruyasu Sugano   Ichizo Tsujino   Koichiro Yoshioka   Naoki Shiota   Shinichi Tanaka   Chieko Yamamoto   Nobuhiro Tanabe   Koichiro Tatsumi   
The European respiratory journal 60(1) 2021年11月
Treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remain limited. Selexipag, an oral selective IP prostacyclin-receptor agonist approved for pulmonary arterial hypertension, is a potential treatment option for ...